- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00741832
The Effects of a Positive Expiratory Pressure (PEP) on Dyspnea and Dynamic Hyperinflation During Exercise in Chronic Obstructive Pulmonary Disease (COPD) Patients
The Effects of a Positive Expiratory Pressure (PEP) on Dyspnea and Dynamic Hyperinflation During Exercise in COPD Patients
From the relationship between pathophysiology of chronic obstructive pulmonary disease (COPD), dyspnea, and dynamic hyperinflation during ventilatory increasing, the investigators hypothesize that
- Positive expiratory pressure (PEP) breathing will reduce dyspnea more than normal breathing during exercise in mild to moderate COPD patients.
- PEP breathing will improve dynamic hyperinflation during exercise more than normal breathing in mild to moderate COPD patients.
- PEP breathing will improve cardiorespiratory function during exercise than normal breathing in mild to moderate COPD patients.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Khon Kaen, Thailand, 40002
- Recruiting
- Pulmonary research room of physical therapy department, Faculty of associated medical sciences, Khon Kaen University
-
Contact:
- Tadsawiya Padkao, Bachelor
- Phone Number: +6643202082
- Email: mjz_tad@yahoo.com
-
Principal Investigator:
- Tadsawiya Padkao, Bachelor
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients with stable mild-to-moderate COPD (Both stages: FEV1/FVC < 70%. Mild stage: FEV1 ≥ 80% predicted; Moderate stage: 50% ≤ FEV1 < 80% predicted according to Global Initiative Obstructive Lung Disease (GOLD) guideline).
- Free of exacerbations for more than 4 weeks (as defined by a change to pharmacological therapy, admission to hospital or ER or unscheduled clinic visit).
- Good communication
Exclusion Criteria:
- Older than 70 years old
- Musculoskeletal problems that limit mobility
- Cardiovascular disease
- Neurological or psychiatric illness
- Patient on long term oxygen or domiciliary noninvasive positive pressure ventilation
- Any other comorbidities which would affect ability to undertake exercise test
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: I
Patients breath while a conical positive expiratory pressure device during exercises
|
Conical positive expiratory pressure device (C-PEP) in this study was designed on the principle of expiratory flow retardation. The principle occurs when exhaling through a small tube diameter, i.e. a small straw, pursed lip breathing, or positive expiratory pressure. Expiratory retardation, results from a decrease in tube diameter, creates flow resistance during exhalation. With flow resistance, the greater the flow the greater the back pressure, and the less the flow the lower the pressure. Expiratory retardation was applied in an attempt to facilitate exhalation and to relieve the air trapping. The optimal design was found to be: cone shape, proximal diameter is 2.0 cm, distal diameter is 0.6 cm, and length is 2.5 cm. Subjects will rest for 10-15 minutes until HR, BP are stabilized. They will undertake 15 min of alternating quadriceps exercise (30% 1 RM) either breathing with the C-PEP device. |
Active Comparator: C
Patients (normal) breath during exercise
|
Subjects will rest for 10-15 minutes until HR, BP are stabilized.
They will undertake 15 min of alternating quadriceps exercise (30% 1 RM) either breathing normally.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Inspiratory Capacity
Time Frame: at 0th, 5th, ~20th minutes of exercises
|
at 0th, 5th, ~20th minutes of exercises
|
Borg scale
Time Frame: at 0th and 20th minutes of exercises
|
at 0th and 20th minutes of exercises
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Heart Rate
Time Frame: every minutes of exercise and recovery periods
|
every minutes of exercise and recovery periods
|
Exercise time
Time Frame: at the times when participants stop exercises
|
at the times when participants stop exercises
|
Recovery time
Time Frame: the periods between end of symptomatic limited constance workload exercises to full recovery heart rate
|
the periods between end of symptomatic limited constance workload exercises to full recovery heart rate
|
Respiratory rate
Time Frame: every minutes of exercise and recovery periods
|
every minutes of exercise and recovery periods
|
Inspiratory time
Time Frame: every minutes of exercise and recovery periods
|
every minutes of exercise and recovery periods
|
Expiratory time
Time Frame: every minutes of exercise and recovery periods
|
every minutes of exercise and recovery periods
|
Sp02
Time Frame: every minutes of exercise and recovery periods
|
every minutes of exercise and recovery periods
|
PetCO2
Time Frame: every minutes of exercise and recovery periods
|
every minutes of exercise and recovery periods
|
Mouth pressure
Time Frame: every minutes of exercise periods
|
every minutes of exercise periods
|
Flow rate
Time Frame: every minutes of exercise periods
|
every minutes of exercise periods
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Watchara Boonsawat, Philosophy, Department of Medicine, Faculty of Medicine, Khon Kaen University
- Study Chair: Tadsawiya Padkao, Bachelor, Physical Therapy department, Faculty of Associated Medical Sciences, Khon Kaen university
- Study Director: Chulee CU Jones, Philosophy, Phusical Therapy Department, Faculty of Associated Medical Sciences, Khon Kaen university, Thailand
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KKU-4950900021
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Obstructive Pulmonary Disease
-
Spire, Inc.ResMedCompletedSevere Chronic Obstructive Pulmonary Disease | Moderate Chronic Obstructive Pulmonary DiseaseUnited States
-
Karaganda Medical UniversityCompletedChronic Obstructive Pulmonary Disease | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereKazakhstan
-
Randall DebattistaUniversity of Malta, Faculty of Health SciencesNot yet recruitingChronic Obstructive Pulmonary Disease Moderate | Acute Exacerbation of COPD | Chronic Obstructive Pulmonary Disease Severe
-
Cukurova UniversityCompletedAnesthesia | Chronic Obstructive Pulmonary Disease Moderate | Lungcancer | Chronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease MildTurkey
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
Taipei Medical UniversityUnknownChronic Obstructive Pulmonary Disease Severe | Chronic Obstructive Pulmonary Disease End StageTaiwan
-
Kırıkkale UniversityRecruitingCOPD (Chronic Obstructive Pulmonary Disease)Turkey
-
Hopital FochAir Liquide SARecruitingChronic Obstructive Pulmonary Disease SevereFrance
-
Fundación para la Investigación del Hospital Clínico...Not yet recruitingCOPD, Chronic Obstructive Pulmonary DiseaseSpain
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
Clinical Trials on Conical Positive Expiratory Pressure Device (C-PEP)
-
Riphah International UniversityCompletedPEP Breathing Versus Incentive Spirometry on Dyspnea and Sputum Profile in Bronchiolectasis PatientsBronchiolectasisPakistan
-
University of Colorado, DenverCompleted
-
Oslo University HospitalCompleted
-
Hospital de Clinicas de Porto AlegreCompletedChronic Obstructive Pulmonary Disease (COPD)Brazil
-
Western University, CanadaNot yet recruitingSurgery | Surgery--Complications | Pulmonary Complication
-
Riphah International UniversityRecruiting
-
Khon Kaen UniversityThailand Research FundUnknown
-
Poudre Valley Health SystemMonaghan Medical CorporationRecruitingRespiratory Complication | Rib FracturesUnited States
-
Lawson Health Research InstituteUnknownCardiac Surgery | Chronic Obstructive Pulmonary Disease (COPD) | Older Adults | Coronary Artery Bypass Grafting | Postoperative Pulmonary ComplicationsCanada
-
Instituto Nacional de Cancerologia de MexicoActive, not recruitingLung Cancer | Mediastinal Tumor | Pleural TumorMexico